Stephen J. Ubl, president and CEO of PhRMA, said the industry is “answering President Trump’s call to put America first by strengthening America’s leadership, improving access for patients and supporting good-paying jobs.”
Trump tariff threat spurs domestic pharmaceutical manufacturing
→
It would mean less treatments and cures and would jeopardize the hundreds of billions our member companies are planning to invest in America — threatening jobs, hurting our economy and making us more reliant on China for innovative medicines," he said.
Trump tackles drug prices, forces Big Pharma to charge Americans same low prices charged abroad
→
